Evidence map›Paper›PMID 38293311›Full record

ArticleInfection and drug resistance2024

Isolation and Phenotypic Characterization of Virulent Bacteriophages Against Multidrug-Resistant

Ashetu Fikadu, Stephen Amankwah, Bikila Alemu, Yared Alemu, Adisu Naga, Esayas Tekle, Tesfaye Kassa

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Characterization and genomic analysis of aFrontiers in microbiology · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ashetu FikaduSchool of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.ORCID 0000-0001-9414-6104
Stephen AmankwahDepartment of Medical Laboratory, Accra Medical Centre, Accra, Ghana.ORCID 0000-0002-0397-5810
Bikila AlemuSchool of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
Yared AlemuSchool of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
Adisu NagaDepartment of Public Health Emergency Management, Kelem Wollega Zone Health Office, Dambi Dollo, Ethiopia.ORCID 0000-0003-4050-8370
Esayas TekleDepartment of Medical Laboratory, Wollega University, Nekemte, Ethiopia.ORCID 0000-0002-6833-6665
Tesfaye KassaSchool of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.ORCID 0000-0001-5259-2245
Jimma University · ETWollega University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The use of lytic bacteriophages for the control or elimination of pathogenic multidrug-resistant (MDR) bacteria is the promising alternative. However, the emergence of resistant bacterial variants after phage application may challenge its therapeutic benefit. In this study, we aimed to isolate candidate phages from sewage samples against two MDR Methods: MDR Results: Out of the first round of phage isolation process, two lytic phages were identified as VBO- Conclusion: While the wild-type MDR pathogen could easily evolve resistance when exposed to a single phage infection by VBO-

Indexed as

E. coliJimma Medical Centermultidrug resistancephagephage-resistancesewage

Identifiers

PMID38293311
PMCPMC10825468
OpenAlexW4391223905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.